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ABSTRACT
Background: Peripheral neuroblast neoplasms are considered as a group of tumors derived from primitive cells of the neural 
crest that are progenitors of the sympathetic ganglia and adrenal medulla. Reports of neuroblastoma in dogs are scarce 
in English literature, and there are no reports from Brazil due to its rare occurrence or missed diagnosis, because modern 
techniques are often not accessible in Brazil. The aim of the present study was reported a case of metastatic peripheral 
neuroblastoma in a 10-month-old bitch of Canadian Shepherd breed.
Case: A 10-month-old female dog, Canadian Shepherd breed, presenting prostration, inappetence, emesis, progressive 
weight loss, and difficulties in the locomotion of the pelvic limbs was brought to the Small Animal Veterinary Hospital of 
the Federal Rural University of Rio de Janeiro (HVPA / UFRRJ) for treatment. Palpation of the abdominal cavity revealed 
a mass of approximately 14.0-cm diameter in the thoracolumbar region. After the second visit to HVPA/ UFRRJ, there 
was worsening of the clinical condition and onset of pain and dyspnea; hence, euthanasia was performed. The dog was 
referred for necropsy; the examination revealed a mass measuring 40.0 × 35.0 cm in the abdominal cavity that caused 
displacement of the intestines and compressed the liver against the diaphragm, as well as another mass that traversed the 
diaphragm through the esophageal hiatus and surrounded the esophagus, aorta, and caudal vena cava. The right adrenal 
gland was compressed and adhered to the mass, and the left adrenal gland was not visualized. Specimens of various 
organs were collected, fixed in 10% buffered formalin, and processed according to routine histological technique. Im-
munohistochemical examination performed on mass specimens revealed positivity for the anti-CD56, anti-synaptophysin, 
anti-GFAP, and anti-NSE markers and negativity for the anti-chromogranin and anti-Olig2 markers. Based on pathology 
and immunohistochemistry findings, a diagnosis of poorly differentiated peripheral neuroblastoma was made; in addition, 
presence of emboli of neoplastic cells in the hepatic sinusoids and branches of the portal vein and metastasis in the spleen, 
lymph nodes, lung, and meninges were confirmed.
Discussion: Positive results for neural markers associated with negative results for those of other small round cell tumors 
was considered to indicate the presence of neuroblast tumors; glioblastoma and oligodendroglioma were ruled out based 
on the absence of anti-Olig2 labeling, and, especially, the possibility of occurrence of pheochromocytoma was excluded 
based on the absence of anti-chromogranin. During necropsy, the location of the mass at the retroperitoneal space near 
the thoracolumbar junction, craniomedially in relation to the left kidney, was confirmed, which is compatible with the 
location of the adrenal gland. Metastasis in the dura mater was determined to be present based on necropsy findings alone, 
and neoplastic invasion through the esophageal hiatus of the diaphragm of a large part of the thoracic cavity was observed, 
which, to the best of our knowledge, have not been described in reports of Veterinary Medicine. The high rate of tumor 
growth and compression and invasion of adjacent tissues and organs may be considered as potential factors for unfavorable 
prognosis of peripheral neuroblastoma.
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INTRODUCTION
Peripheral neuroblast neoplasms are conside-
red as a group of tumors derived from primitive cells of 
the neural crest; such cells are responsible for forming 
the sympathetic ganglia and the medullary adrenal 
region. The frequency and pathogenesis of neuroblas-
toma in animals are unknown [3,9,19]; in contrast, in 
humans, it is considered a common neoplasia mainly 
in children up to 2 years old [12] and involves patho-
genetic factors of exposure to environmental factors, 
prenatal alcohol consumption, use of pesticides, and 
phenobarbital [2].
Clinical signs are nonspecific and include 
lethargy, anorexia, pain, fever, and weight-loss. Other 
less common signs are derived from tumor develop-
ment and consequent deleterious effects of compres-
sion of the adjacent organs [5].
Generally, peripheral neuroblastoma is charac-
terized by formation of large abdominal masses with 
high capacity for infiltration and metastasis [6].
In human medicine, treatment is selected ac-
cording to the International Neuroblastoma Patholo-
gical Classification (INSS) status [12,18]; whereas, in 
veterinary medicine, there are no reports of treatment 
options or attempts in patients with peripheral neu-
roblastoma, due to the fact that euthanasia is usually 
performed before confirming the diagnosis, or the guar-
dian does not seek further clinical care [1,3,6-10,13].
In this study, we reported our experience of 
a case of metastatic peripheral neuroblastoma in a 
10-month-old bitch of Canadian Shepherd breed.
CASE
A 10-month-old bitch, Canadian Shepherd 
breed, was brought to the Small Animal Veterinary 
Hospital of the Federal Rural University of Rio de 
Janeiro (HVPA / UFRRJ) for treatment. The guardian 
reported that for 4 months prior to visit, the patient 
had presented prostration, inappetence, emesis, pro-
gressive weight loss, and difficulties in locomotion of 
the pelvic limbs.
Clinical examination revealed moderate ca-
chexia and alert state of consciousness, and tempera-
ture of 38ºC, heart rate of 124 bpm, and respiratory 
rate of 36 rpm. The mucosae were normocorated and 
no enlarged superficial lymph node was observed; 
palpation of the abdominal cavity revealed a mass of 
soft consistency, approximately 14.0 cm in diameter, 
located in the thoracolumbar region and slightly dis-
placed to the right side. Based on clinical findings, ra-
diography of the spine and abdominal ultrasonography 
were performed; the results revealed decreases in the 
intervertebral spaces of the lumbar vertebrae, diffuse 
splenomegaly, and increased volume in the soft tissues 
located in the third of the right thoracic region, and 
initial third of the right dorsal lumbar region, without 
bone involvement.
Analgesic therapy with dipyrone1 (25 mg/kg 
tid), tramadol hydrochloride2 (4 mg/kg bid), carprofen3 
(4.4 mg/kg sid), and supportive treatment with omepra-
zole4 (1 mg/kg sid), and cobavital5 (0.4 mg/kg) were 
administered. The hemogram revealed normocytic 
normochromic anemia and leukopenia due to lym-
phopenia, both discrete; serum biochemistry showed 
a slight decrease in alkaline phosphatase, alanine ami-
notransferase, and aspartate aminotransferase.
Fine needle aspiration cytology was perfor-
med, and findings obtained indicated low cellularity 
and inconclusive diagnosis. Subsequently, incisional 
biopsy of the patient under anesthesia was performed 
with a tru-cut and punch needle of 3.0 mm under ultra-
sonography guidance. Two fragments were collected 
and fixed in 10% buffered formalin and sent to the 
Pathology Department of the Federal Rural University 
of Rio de Janeiro (SAP / UFRRJ).
Histopathological examination revealed proli-
feration of neoplastic cells with indistinct cytoplasmic 
boundaries, sparse and discreetly eosinophilic cyto-
plasm, and an oval nucleus with condensed or coarsely 
granular chromatin, with the nucleolus not visualized; 
in addition, moderate anisocytosis and anisokaryosis 
and mitotic figures in 10 fields of greatest magnification 
(400x) were observed. Based on these findings, poorly 
differentiated sarcoma was diagnosed.
Due to worsening of the patient’s clinical 
condition and onset of pain and dyspnea, euthanasia 
was performed by the tutors. The animal was referred 
for necropsy. The examination revealed a mass of 40.0 
x 35.0 cm in the abdominal cavity, with a reddish-
-colored, multinodular irregular external surface that 
caused displacement of the small and large intestines 
and compression of the liver against the diaphragm; 
moreover, there was spread of the mass through the 
esophageal hiatus of the diaphragm, surrounding the 
esophagus, aorta, and caudal vena cava. The thoracic 
portion of the mass was 20.0 x 10.0 cm, with the same 
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morphological characteristics as that in the abdominal 
cavity; the right adrenal gland was compressed and 
adhered to the tumor, whereas, the left adrenal was 
missing; mass infiltration at the dorsal muscles and 
vertebral canal, and compression of the spinal cord 
at level of T10 to L5 was observed. Weight of tumor 
on removal from the abdominal cavity was 2.0 kg, 
and soft consistency on cutting with reddish tint of 
compact cut surface was noted. At the opening of the 
skull, three circumscribed areas of 0.5 cm in the dura 
were visualized, with irregular slightly rough surface 
and reddish tonality.
Specimens of the tumor and various tissues 
(the adrenal, liver, lymph nodes, heart, lung, stomach, 
intestine, pancreas, spleen, kidney, bladder, meninges, 
and central nervous system) were collected, fixed in 
10% buffered formalin, and processed according to 
routine histological technique; paraffin blocks contai-
ning fragments of the neoplasia were submitted for im-
munohistochemistry including the following markers: 
anti-CD56, anti-synaptophysin, anti-GFAP, anti-NSE 
(enolase specific neuron), anti-chromogranin, and 
anti-Olig2.
Microscopy revealed proliferation of neoplas-
tic cells, densely cellular lesion arranged in nests, and 
packages supported by fine fibrovascular stroma and 
separated into lobes by thick fibrous septa. Neoplastic 
cells were oval to polygonal, with moderately distinct 
limits, and moderate cytoplasm slightly eosinophilic 
and granular. The nucleus was round to oval, and 
characterized as hyperchromatic or with chromatin 
finely dotted with one to two visible nucleoli. Pleo-
morphism, anisocytosis, and moderate anisokaryosis 
were observed, and seven mitosis figures were visua-
lized per magnification (400x) field. Areas of central 
necrosis were present in some neoplastic cell nests 
(Figures 1-2).
Immunohistochemical examination revealed 
positivity for anti-CD56 (Figure 3), anti-synaptophysin 
(Figure 4), anti-GFAP (Figure 5), and anti-NSE (Fi-
gure 6) markers, and negativity for anti-chromogranin 
(Figure 7) and anti-Olig2 (Figure 8) markers.
Based on the pathology and immunohisto-
chemistry findings of a neoplasm with predominance 
of neuroblasts with <5% of ganglion cells and low 
Schwannoma tumor, poorly differentiated peripheral 
neuroblastoma was diagnosed; presence of emboli of 
the cells in the hepatic sinusoids and branches of the 
portal vein, and metastasis in the spleen, lymph nodes, 
lung, and meninges were confirmed.
1
2
Figures 1 & 2. Peripheral neuroblastoma in a Canadian Shepherd Dog. 
Clusters of tightly packed cells divided by moderated fibrovascular stroma. 
Neoplastic cells have moderate distinct borders and scant cytoplasm 
[HE; 400x].
Figure 3. Diffuse and strong perimembranous and membranous labeling 
for CD56 in the neuroblastic cells [CD56; 40x].
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DISCUSSION
In this case, the diagnosis of peripheral neuro-
blastoma was made based on the findings of pathology 
and immunohistochemistry. The tumor was positive for 
anti-CD56, anti-GFAP, anti-synaptophysin, and anti-
-NSE antibodies and negative for anti-chromogranin 
and anti-Olig2. Positive results for neural markers 
combined with negative results for other markers of 
small round cell tumors were considered to indicate 
the presence of neuroblast tumors [12], and the absen-
ce of anti-Olig2 labeling was considered to rule out 
glioblastoma and oligodendroglioma; especially, the 
possibility of occurrence of pheochromocytoma was 
excluded based on the absence of anti-chromogranin.
By histological definition, neuroblastoma is a 
tumor comprising neuroblasts arranged in groups with 
or without proliferation of Schwann cells. Differential 
diagnoses include peripheral neuroblast tumors, such 
as ganglioneuroblastoma and ganglioneuroma [1]. 
Ganglioneuroblastoma is characterized by foci of neu-
roblasts at various stages of differentiation randomly 
mixed with mature ganglion cells and arranged on 
abundant Schwannian stroma [17].
Figure 8. Chromaffin cells were positive for chromogranin A in the 
adrenal medulla. Neoplastic cells failed to express immunoreactivity 
[Chromogranin; 5x].
Figure 4. Diffuse and strong perimembranous and membranous labeling 
for and anti-synaptophysin [40x].
Figure 5. Mature neuronal cells showed strong membranous immunore-
activity for GFAP [20x].
Figure 6. Neuronal cells showed immunoreactivity diffuse cytoplasmic 
labeling for NSE [40x].
Figure 7. Neoplastic cells were negative for Olig2 [40x].
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Peripheral neuroblastoma in dogs remains 
unclear due to scarcity of reports in English literature, 
and absence of reported studies in Brazil which reflects 
rare incidence of this neoplasm.
In our case, the patient age was <1 year, similar 
to that of cases described previously with patient age 
<2 years [6-10,13]. Reports have indicated diagnosis 
of peripheral neuroblastoma in dogs aged 4, 8, and 10 
years [1,3].
Diarrhea may occur due to ability of this tumor 
to secrete vasoactive intestinal polypeptides, as in pa-
tients with Kerner-Morrison syndrome [16].
During necropsy, location of the mass at re-
troperitoneal space, near the thoracolumbar junction, 
craniomedially in relation to the left kidney was noted, 
which was compatible with location of the adrenal gland. 
The pluripotent cells are the tumors’ source and migrate 
from the neural crest to form the sympathetic ganglia, 
paragranules, and medullary adrenal region [12].
In our patient, metastasis in the dura mater was 
detected based on necropsy findings alone, and inva-
sion of the neoplasm through the esophageal hiatus of 
the diaphragm and its wide spread within the thoracic 
cavity was observed; to the best of our knowledge, this 
has not been previously described in the literature, and 
occurrence of epidural and intradural metastasis has 
only been reported in humans [4].
In microscopic analysis, a small number of 
individualized cells were observed, with abundant 
cytoplasm and eosinophilic and large and oval nuclei 
compatible with ganglion cells [1,3,10].
No cases of peripheral neuroblastoma in ve-
terinary medicine have been managed with treatment 
modalities used in human medicine, such as surgery, 
chemotherapy, and radiotherapy; in some cases, the 
patient died due to anesthesia performed during the 
biopsy, or it was not feasible to perform the treatment 
due to poor clinical conditions or high treatment 
cost. Considering these situations combined with 
the high rate of tumor growth, and compression and 
invasion of the adjacent tissues and organs, peripheral 
neuroblastoma is considered to have an unfavorable 
prognosis [11,16].
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